Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
A randomized, phase 3, open-label trial comparing the effect of the addition of tirzepatide once weekly versus insulin lispro (U100) three times daily in participants with type 2 diabetes inadequately controlled on insulin glargine (U100) with or without metformin (SURPASS-6)
MicroRNAs as novel targets of sulforaphane in cancer therapy: the beginning of a new tale
The broader risk with any peptide therapy is using unregulated, online-sourced peptides without medical supervision
You have 12 months of unlimited access from the date of enrollment, including after you complete the course
Your lab results, medical history, and provider communications are safely stored and easily accessible
US$ 28.81
US$ 25.31
US$ 25.16
US$ 27.88
US$ 20.67
US$ 25.45
US$ 26.74
US$ 21.63
